HEADER SUGAR BINDING PROTEIN 23-AUG-17 6AS8 TITLE F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED TITLE 2 WITH ORTHO-BIPHENYL-2'-CARBOXYL N-ACETYL-BETA-GALACTOSAMINOSIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FML FIMBRIAL ADHESIN FMLD; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 364106; SOURCE 4 STRAIN: UTI89 / UPEC; SOURCE 5 GENE: FMLD, UTI89_C1716; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C600 KEYWDS FIMBRIAL ADHESIN, LECTIN, BACTERIAL ADHESION, SUGAR BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR V.KALAS,S.J.HULTGREN REVDAT 6 23-OCT-24 6AS8 1 REMARK REVDAT 5 04-OCT-23 6AS8 1 HETSYN REVDAT 4 29-JUL-20 6AS8 1 COMPND REMARK HETNAM SITE REVDAT 4 2 1 ATOM REVDAT 3 25-DEC-19 6AS8 1 REMARK REVDAT 2 11-SEP-19 6AS8 1 JRNL REVDAT 1 28-FEB-18 6AS8 0 JRNL AUTH V.KALAS,M.E.HIBBING,A.R.MADDIRALA,R.CHUGANI,J.S.PINKNER, JRNL AUTH 2 L.K.MYDOCK-MCGRANE,M.S.CONOVER,J.W.JANETKA,S.J.HULTGREN JRNL TITL STRUCTURE-BASED DISCOVERY OF GLYCOMIMETIC FMLH LIGANDS AS JRNL TITL 2 INHIBITORS OF BACTERIAL ADHESION DURING URINARY TRACT JRNL TITL 3 INFECTION. JRNL REF PROC.NATL.ACAD.SCI.USA V. 115 E2819 2018 JRNL REFN ESSN 1091-6490 JRNL PMID 29507247 JRNL DOI 10.1073/PNAS.1720140115 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.8 REMARK 3 NUMBER OF REFLECTIONS : 16419 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 824 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.1945 - 3.8170 1.00 3122 164 0.1823 0.2159 REMARK 3 2 3.8170 - 3.0299 1.00 2966 157 0.1827 0.2196 REMARK 3 3 3.0299 - 2.6469 1.00 2943 164 0.2177 0.2526 REMARK 3 4 2.6469 - 2.4049 0.93 2730 135 0.2286 0.2797 REMARK 3 5 2.4049 - 2.2325 0.77 2237 114 0.2327 0.2953 REMARK 3 6 2.2325 - 2.1009 0.55 1597 90 0.2719 0.3180 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2450 REMARK 3 ANGLE : 0.811 3362 REMARK 3 CHIRALITY : 0.029 386 REMARK 3 PLANARITY : 0.003 426 REMARK 3 DIHEDRAL : 10.847 836 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6AS8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1000229704. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16455 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.7 REMARK 200 DATA REDUNDANCY : 10.70 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 44.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.530 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6AOW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.7 M LISO4, 2% PEG8000, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.75950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.74800 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 25.75950 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 58.74800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 303 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 357 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 112 REMARK 465 ALA A 113 REMARK 465 ALA A 114 REMARK 465 GLY A 115 REMARK 465 THR A 158 REMARK 465 GLY A 159 REMARK 465 GLY A 160 REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 465 HIS A 163 REMARK 465 HIS A 164 REMARK 465 HIS A 165 REMARK 465 HIS A 166 REMARK 465 GLY B 112 REMARK 465 ALA B 113 REMARK 465 ALA B 114 REMARK 465 GLY B 115 REMARK 465 THR B 158 REMARK 465 GLY B 159 REMARK 465 GLY B 160 REMARK 465 HIS B 161 REMARK 465 HIS B 162 REMARK 465 HIS B 163 REMARK 465 HIS B 164 REMARK 465 HIS B 165 REMARK 465 HIS B 166 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 68 CG CD OE1 NE2 REMARK 470 LYS A 71 CG CD CE NZ REMARK 470 GLN B 68 CG CD OE1 NE2 REMARK 470 LYS B 71 CG CD CE NZ REMARK 470 LYS B 120 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H ASP A 51 O HOH A 301 1.55 REMARK 500 O HOH B 341 O HOH B 355 1.91 REMARK 500 O HOH A 322 O HOH A 356 1.94 REMARK 500 O HOH B 334 O HOH B 352 2.17 REMARK 500 O HOH A 340 O HOH A 351 2.17 REMARK 500 O HOH B 356 O HOH B 358 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O PRO B 28 OH TYR B 46 1655 2.11 REMARK 500 O HOH A 323 O HOH B 316 2597 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 39 -46.18 -133.81 REMARK 500 ALA B 134 -153.45 -94.83 REMARK 500 REMARK 500 REMARK: NULL DBREF 6AS8 A 1 160 UNP Q1RBS0 Q1RBS0_ECOUT 25 184 DBREF 6AS8 B 1 160 UNP Q1RBS0 Q1RBS0_ECOUT 25 184 SEQADV 6AS8 HIS A 161 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS A 162 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS A 163 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS A 164 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS A 165 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS A 166 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS B 161 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS B 162 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS B 163 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS B 164 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS B 165 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AS8 HIS B 166 UNP Q1RBS0 EXPRESSION TAG SEQRES 1 A 166 PHE SER CYS ASN VAL ASP GLY GLY SER SER ILE GLY ALA SEQRES 2 A 166 GLY THR THR SER VAL TYR VAL ASN LEU ASP PRO VAL ILE SEQRES 3 A 166 GLN PRO GLY GLN ASN LEU VAL VAL ASP LEU SER GLN HIS SEQRES 4 A 166 ILE SER CYS TRP ASN ASP TYR GLY GLY TRP TYR ASP THR SEQRES 5 A 166 ASP HIS ILE ASN LEU VAL GLN GLY SER ALA PHE ALA GLY SEQRES 6 A 166 SER LEU GLN SER TYR LYS GLY SER LEU TYR TRP ASN ASN SEQRES 7 A 166 VAL THR TYR PRO PHE PRO LEU THR THR ASN THR ASN VAL SEQRES 8 A 166 LEU ASP ILE GLY ASP LYS THR PRO MET PRO LEU PRO LEU SEQRES 9 A 166 LYS LEU TYR ILE THR PRO VAL GLY ALA ALA GLY GLY VAL SEQRES 10 A 166 VAL ILE LYS ALA GLY GLU VAL ILE ALA ARG ILE HIS MET SEQRES 11 A 166 TYR LYS ILE ALA THR LEU GLY SER GLY ASN PRO ARG ASN SEQRES 12 A 166 PHE THR TRP ASN ILE ILE SER ASN ASN SER VAL VAL MET SEQRES 13 A 166 PRO THR GLY GLY HIS HIS HIS HIS HIS HIS SEQRES 1 B 166 PHE SER CYS ASN VAL ASP GLY GLY SER SER ILE GLY ALA SEQRES 2 B 166 GLY THR THR SER VAL TYR VAL ASN LEU ASP PRO VAL ILE SEQRES 3 B 166 GLN PRO GLY GLN ASN LEU VAL VAL ASP LEU SER GLN HIS SEQRES 4 B 166 ILE SER CYS TRP ASN ASP TYR GLY GLY TRP TYR ASP THR SEQRES 5 B 166 ASP HIS ILE ASN LEU VAL GLN GLY SER ALA PHE ALA GLY SEQRES 6 B 166 SER LEU GLN SER TYR LYS GLY SER LEU TYR TRP ASN ASN SEQRES 7 B 166 VAL THR TYR PRO PHE PRO LEU THR THR ASN THR ASN VAL SEQRES 8 B 166 LEU ASP ILE GLY ASP LYS THR PRO MET PRO LEU PRO LEU SEQRES 9 B 166 LYS LEU TYR ILE THR PRO VAL GLY ALA ALA GLY GLY VAL SEQRES 10 B 166 VAL ILE LYS ALA GLY GLU VAL ILE ALA ARG ILE HIS MET SEQRES 11 B 166 TYR LYS ILE ALA THR LEU GLY SER GLY ASN PRO ARG ASN SEQRES 12 B 166 PHE THR TRP ASN ILE ILE SER ASN ASN SER VAL VAL MET SEQRES 13 B 166 PRO THR GLY GLY HIS HIS HIS HIS HIS HIS HET BTG A 201 52 HET BTG B 201 52 HETNAM BTG ORTHO-BIPHENYL-2'-CARBOXYL N-ACETYL-BETA- HETNAM 2 BTG GALACTOSAMINOSIDE HETSYN BTG 2'-{[2-(ACETYLAMINO)-2-DEOXY-BETA-D- HETSYN 2 BTG GALACTOPYRANOSYL]OXY}[1,1'-BIPHENYL]-3-CARBOXYLIC ACID FORMUL 3 BTG 2(C21 H23 N O8) FORMUL 5 HOH *126(H2 O) HELIX 1 AA1 GLY A 65 GLN A 68 5 4 HELIX 2 AA2 GLY B 65 TYR B 70 5 6 SHEET 1 AA1 3 SER A 2 VAL A 5 0 SHEET 2 AA1 3 ILE A 40 TRP A 43 -1 O TRP A 43 N SER A 2 SHEET 3 AA1 3 MET A 100 PRO A 101 -1 O MET A 100 N CYS A 42 SHEET 1 AA2 4 GLY A 14 VAL A 20 0 SHEET 2 AA2 4 ARG A 142 SER A 150 1 O ILE A 149 N VAL A 18 SHEET 3 AA2 4 VAL A 124 ILE A 133 -1 N MET A 130 O PHE A 144 SHEET 4 AA2 4 ALA A 62 PHE A 63 -1 N ALA A 62 O ARG A 127 SHEET 1 AA3 5 GLY A 14 VAL A 20 0 SHEET 2 AA3 5 ARG A 142 SER A 150 1 O ILE A 149 N VAL A 18 SHEET 3 AA3 5 VAL A 124 ILE A 133 -1 N MET A 130 O PHE A 144 SHEET 4 AA3 5 ASP A 53 LEU A 57 -1 N ASN A 56 O TYR A 131 SHEET 5 AA3 5 LEU A 92 ILE A 94 -1 O LEU A 92 N ILE A 55 SHEET 1 AA4 4 LEU A 32 ASP A 35 0 SHEET 2 AA4 4 LEU A 104 THR A 109 -1 O ILE A 108 N LEU A 32 SHEET 3 AA4 4 LYS A 71 TRP A 76 -1 N SER A 73 O TYR A 107 SHEET 4 AA4 4 VAL A 79 PHE A 83 -1 O TYR A 81 N LEU A 74 SHEET 1 AA5 2 VAL A 117 ILE A 119 0 SHEET 2 AA5 2 VAL A 154 VAL A 155 -1 O VAL A 154 N VAL A 118 SHEET 1 AA6 3 SER B 2 VAL B 5 0 SHEET 2 AA6 3 ILE B 40 TRP B 43 -1 O TRP B 43 N SER B 2 SHEET 3 AA6 3 MET B 100 PRO B 101 -1 O MET B 100 N CYS B 42 SHEET 1 AA7 4 GLY B 14 VAL B 20 0 SHEET 2 AA7 4 ARG B 142 SER B 150 1 O ASN B 147 N VAL B 18 SHEET 3 AA7 4 VAL B 124 ILE B 133 -1 N MET B 130 O PHE B 144 SHEET 4 AA7 4 ALA B 62 PHE B 63 -1 N ALA B 62 O ARG B 127 SHEET 1 AA8 5 GLY B 14 VAL B 20 0 SHEET 2 AA8 5 ARG B 142 SER B 150 1 O ASN B 147 N VAL B 18 SHEET 3 AA8 5 VAL B 124 ILE B 133 -1 N MET B 130 O PHE B 144 SHEET 4 AA8 5 ASP B 53 LEU B 57 -1 N ASN B 56 O TYR B 131 SHEET 5 AA8 5 LEU B 92 ILE B 94 -1 O ILE B 94 N ASP B 53 SHEET 1 AA9 4 LEU B 32 ASP B 35 0 SHEET 2 AA9 4 LEU B 104 THR B 109 -1 O LEU B 106 N VAL B 34 SHEET 3 AA9 4 LYS B 71 TRP B 76 -1 N LYS B 71 O THR B 109 SHEET 4 AA9 4 VAL B 79 PHE B 83 -1 O TYR B 81 N LEU B 74 SHEET 1 AB1 2 VAL B 117 ILE B 119 0 SHEET 2 AB1 2 VAL B 154 VAL B 155 -1 O VAL B 154 N VAL B 118 SSBOND 1 CYS A 3 CYS A 42 1555 1555 2.03 SSBOND 2 CYS B 3 CYS B 42 1555 1555 2.03 CISPEP 1 PRO A 28 GLY A 29 0 -4.21 CISPEP 2 PHE A 83 PRO A 84 0 6.24 CISPEP 3 PHE B 83 PRO B 84 0 4.64 CRYST1 50.957 51.519 117.496 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019624 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019410 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008511 0.00000